#160388

INA-6-CD63-EGFP cell line

Cat. #160388

INA-6-CD63-EGFP cell line

Cat. #: 160388

Sub-type: Continuous

Unit size: 1x10^6 cells / vial

Organism: Human

Tissue: Blood

Disease: Cancer

£575.00

This fee is applicable only for non-profit organisations. If you are a for-profit organisation or a researcher working on commercially-sponsored academic research, you will need to contact our licensing team for a commercial use license.

Contributor

Inventor: Gaute Brede

Institute: Norwegian University of Science and Technology (NTNU)

Tool Details
Target Details
Handling

Tool Details

*FOR RESEARCH USE ONLY

  • Name: INA-6-CD63-EGFP cell line
  • Cancer: Blood cancer
  • Cancers detailed: Myeloma
  • Research fields: Cell biology
  • Tool sub type: Continuous
  • Parental cell: INA6
  • Organism: Human
  • Tissue: Blood
  • Disease: Cancer
  • Description: This human myeloma cell line expresses CD63-EGFP that labels extracellular vesicles including exosomes and microvesicles (EVs). The cell line is useful for the study of EV exchange between donor and acceptor cells and also for the study of tunnelling nanotubes (TnTs). The cell line is particularly useful for interaction-studies between myeloma and stroma-cells.
  • Cellosaurus id: CVCL_5209

Target Details

  • Target: INA6-CD63

Handling

  • Format: Frozen
  • Growth medium: Culture in RPMI-1640 with 5% heat inactivated fetal calf serum (FCS) added with 1 ng/ml IL-6 and 200 ?„?žg/ml G418 (Geneticin) at 37?‚°C in a humidified atmosphere containing 5% CO2.
  • Unit size: 1x10^6 cells / vial
  • Shipping conditions: Dry ice